Glucocorticoid-induced osteoporosis in inflammatory bowel disease

Abstract

Osteoporosis secondary to glucocorticoid use is a potentially preventable disorder. It is the role of the physician to establish and maintain disease remission, minimize the use of glucocorticoids, and initiate measures to prevent and treat bone loss. The essentials of management include lifestyle modifications, nutritional interventions, and pharmacologic therapies. Bisphosphonates should be used when indicated.